Literature DB >> 12031871

Angiogenesis in bladder cancer--prognostic marker and target for future therapy.

Edward H Streeter1, Adrian L Harris.   

Abstract

Angiogenesis is the process by which tumours induce a blood supply, crucial for growth and metastasis. Evidence for its role in bladder carcinogenesis, its usefulness as a marker of patient prognosis, and potential anti-angiogenic therapies for future development are discussed in this chapter.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12031871     DOI： 10.1016/s0960-7404(02)00013-0

Source DB:  PubMed          Journal:  Surg Oncol        ISSN： 0960-7404            Impact factor:   3.279


  13 in total

1.  Prognostic significance of thymidine phosphorylase in superficial bladder carcinoma.

Authors:  N E Stavropoulos; C Bouropoulos; E Ioachim; M Michael; K Hastazeris; I Tsimaris; D Kalogeras; Z Liamis; V Kafarakis; S Stefanaki; V Malamou-Mitsi
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder.

Authors:  Anastasios Tahmatzopoulos; Chad A Lagrange; Li Zeng; Bonnie L Mitchell; William T Conner; Natasha Kyprianou
Journal:  Urology       Date:  2005-05       Impact factor: 2.649

Review 3.  Adjuvant chemotherapy for transitional cell carcinoma of the bladder: paradigms for the design of clinical trials.

Authors:  Michelle Boyar; Daniel P Petrylak
Journal:  Curr Oncol Rep       Date:  2005-05       Impact factor: 5.075

4.  Utility of early dynamic and delayed post-diuretic 18F-FDG PET/CT SUVmax in predicting tumour grade and T-stage of urinary bladder carcinoma: results from a prospective single centre study.

Authors:  Abhishek Sharma; Uttam K Mete; Ashwani Sood; Nandita Kakkar; Arun K R Gorla; Bhagwant R Mittal
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

5.  Inhibitory effect of midkine-binding peptide on tumor proliferation and migration.

Authors:  Hui-Lian Huang; Jian-Fen Shen; Li-Shan Min; Jin-Liang Ping; Yong-Liang Lu; Li-Cheng Dai
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

6.  Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists.

Authors:  Frances M Martin; Andrew M Harris; Randall G Rowland; William Conner; Matthew Lane; Erik Durbin; Andre T Baron; Natasha Kyprianou
Journal:  Gene Ther Mol Biol       Date:  2008

7.  RNA interference targeting adrenomedullin induces apoptosis and reduces the growth of human bladder urothelial cell carcinoma.

Authors:  Ai-guang Liu; Xi-zhong Zhang; Fen-bao Li; Yong-li Zhao; Ying-chang Guo; Rui-min Yang
Journal:  Med Oncol       Date:  2013-05-29       Impact factor: 3.064

8.  Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis.

Authors:  Li-Cheng Dai; Xiang Wang; Xing Yao; Yong-Liang Lu; Jin-Liang Ping; Jian-Fang He
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

9.  EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis.

Authors:  Rebecca A Mason; Elaine V Morlock; Margaret R Karagas; Karl T Kelsey; Carmen J Marsit; Alan R Schned; Angeline S Andrew
Journal:  Carcinogenesis       Date:  2009-04-16       Impact factor: 4.944

10.  Pathobiology and chemoprevention of bladder cancer.

Authors:  Takuji Tanaka; Katsuhito Miyazawa; Tetsuya Tsukamoto; Toshiya Kuno; Koji Suzuki
Journal:  J Oncol       Date:  2011-09-15       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.